Yunfei Zhou
State Key Laboratory Of Digestive Disease
Sar, China
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Corrigendum to "Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice" (Volume 93, 104670, July 2023).
Journal: EBioMedicine
Published: December 06, 2025
Author Correction: Intestinal TM6SF2 protects against metabolic dysfunction-associated steatohepatitis through the gut-liver axis.
Journal: Nature metabolism
Published: January 21, 2025
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice.
Journal: Cell
Published: October 26, 2024
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 10, 2024
VSTM2A reverses immunosuppression in colorectal cancer by antagonizing the PD-L1/PD-1 interaction.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 23, 2024
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
Journal: Gut
Published: September 11, 2023
Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice.
Journal: EBioMedicine
Published: November 11, 2022
METTL3 drives NAFLD-related hepatocellular carcinoma and is a therapeutic target for boosting immunotherapy.
Journal: Cell reports. Medicine
Published: September 12, 2022
Streptococcus anginosus promotes gastric inflammation, atrophy, and tumorigenesis in mice.
Journal: Cell
Published: August 08, 2022
Bifidobacterium pseudolongum-generated acetate suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma.
Journal: Journal of hepatology
Published: July 30, 2022
Last Updated: 09/26/2026